RLITX | VFWPX | RLITX / VFWPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 14 years | - |
Gain YTD | 0.668 | 5.421 | 12% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.32B | 56.7B | 6% |
Annual Yield % from dividends | 1.38 | 3.36 | 41% |
Returns for 1 year | 8.67 | 11.60 | 75% |
Returns for 3 years | -8.92 | -4.92 | 181% |
Returns for 5 years | 14.45 | 16.66 | 87% |
Returns for 10 years | N/A | 30.49 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTIX | 59.94 | 0.32 | +0.54% |
Baron Fifth Avenue Growth Instl | |||
LVFLX | 14.02 | N/A | N/A |
Lord Abbett Focused Large Cap Value R6 | |||
LBRIX | 32.62 | -0.03 | -0.09% |
ClearBridge Dividend Strategy FI | |||
FAVCX | 24.73 | -0.05 | -0.20% |
Fidelity Advisor Equity Value C | |||
FBTCX | 25.11 | -0.37 | -1.45% |
Fidelity Advisor Biotechnology C |